“…IL-18 promotes inflammation indirectly by stimulating IL-1b expression, which by structurally resembling IL-18, binds IL-18 receptors and thus potentiates proinflammation (2, 3) by engaging similar signaling and signal transduction (2,4). Alterations of IL-18 have been investigated in the susceptibility to autoimmune and inflammatory disorders (4,5), and changes in IL-18 levels have been linked with pregnancy complications, including preeclampsia (6,7), preterm delivery (8), IVF-ET failure (9), implantation failure (4,10), and recurrent miscarriage (10)(11)(12).…”